vs
AtriCure, Inc.（ATRC）与PREFORMED LINE PRODUCTS CO（PLPC）财务数据对比。点击上方公司名可切换其他公司
PREFORMED LINE PRODUCTS CO的季度营收约是AtriCure, Inc.的1.2倍（$173.1M vs $140.5M），AtriCure, Inc.同比增速更快（13.1% vs 3.6%），AtriCure, Inc.自由现金流更多（$18.4M vs $11.8M），过去两年AtriCure, Inc.的营收复合增速更高（13.6% vs 10.8%）
AtriCure是一家专注于心房颤动及相关心脏病症治疗的医疗设备企业，研发并生产创新外科手术工具与疗法，主要服务北美、欧洲、亚太地区的医院、心脏外科中心及医疗机构，为微创心脏手术提供高效可靠的适配解决方案。
预成型线路产品公司（PLPC）研发、生产和销售适用于输配电、通信及可再生能源基建领域的工程硬件组件，服务全球多地的公用事业、网络运营商及工业客户，提供可提升网络可靠性与运营效率的解决方案。
ATRC vs PLPC — 直观对比
营收规模更大
PLPC
是对方的1.2倍
$140.5M
营收增速更快
ATRC
高出9.5%
3.6%
自由现金流更多
ATRC
多$6.6M
$11.8M
两年增速更快
ATRC
近两年复合增速
10.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $140.5M | $173.1M |
| 净利润 | — | $8.4M |
| 毛利率 | 75.0% | 29.8% |
| 营业利润率 | 1.8% | 6.8% |
| 净利率 | — | 4.9% |
| 营收同比 | 13.1% | 3.6% |
| 净利润同比 | — | -19.3% |
| 每股收益（稀释后） | $0.04 | $1.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRCPLPC
| Q4 25 | $140.5M | $173.1M | ||
| Q3 25 | $134.3M | $178.1M | ||
| Q2 25 | $136.1M | $169.6M | ||
| Q1 25 | $123.6M | $148.5M | ||
| Q4 24 | $124.3M | $167.1M | ||
| Q3 24 | $115.9M | $147.0M | ||
| Q2 24 | $116.3M | $138.7M | ||
| Q1 24 | $108.9M | $140.9M |
净利润ATRCPLPC
| Q4 25 | — | $8.4M | ||
| Q3 25 | $-267.0K | $2.6M | ||
| Q2 25 | $-6.2M | $12.7M | ||
| Q1 25 | $-6.7M | $11.5M | ||
| Q4 24 | — | $10.5M | ||
| Q3 24 | $-7.9M | $7.7M | ||
| Q2 24 | $-8.0M | $9.4M | ||
| Q1 24 | $-13.3M | $9.6M |
毛利率ATRCPLPC
| Q4 25 | 75.0% | 29.8% | ||
| Q3 25 | 75.5% | 29.7% | ||
| Q2 25 | 74.5% | 32.7% | ||
| Q1 25 | 74.9% | 32.8% | ||
| Q4 24 | 74.5% | 33.3% | ||
| Q3 24 | 74.9% | 31.1% | ||
| Q2 24 | 74.7% | 31.9% | ||
| Q1 24 | 74.7% | 31.3% |
营业利润率ATRCPLPC
| Q4 25 | 1.8% | 6.8% | ||
| Q3 25 | 0.2% | 7.4% | ||
| Q2 25 | -4.5% | 10.1% | ||
| Q1 25 | -4.8% | 8.8% | ||
| Q4 24 | -11.7% | 10.5% | ||
| Q3 24 | -6.4% | 7.1% | ||
| Q2 24 | -6.2% | 8.1% | ||
| Q1 24 | -10.0% | 8.2% |
净利率ATRCPLPC
| Q4 25 | — | 4.9% | ||
| Q3 25 | -0.2% | 1.5% | ||
| Q2 25 | -4.5% | 7.5% | ||
| Q1 25 | -5.5% | 7.8% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | -6.8% | 5.2% | ||
| Q2 24 | -6.9% | 6.8% | ||
| Q1 24 | -12.2% | 6.8% |
每股收益（稀释后）ATRCPLPC
| Q4 25 | $0.04 | $1.72 | ||
| Q3 25 | $-0.01 | $0.53 | ||
| Q2 25 | $-0.13 | $2.56 | ||
| Q1 25 | $-0.14 | $2.33 | ||
| Q4 24 | $-0.33 | $2.13 | ||
| Q3 24 | $-0.17 | $1.54 | ||
| Q2 24 | $-0.17 | $1.89 | ||
| Q1 24 | $-0.28 | $1.94 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.4M | — |
| 总债务越低越好 | — | $38.3M |
| 股东权益账面价值 | $491.9M | $475.5M |
| 总资产 | $654.2M | $653.6M |
| 负债/权益比越低杠杆越低 | — | 0.08× |
8季度趋势，按日历期对齐
现金及短期投资ATRCPLPC
| Q4 25 | $167.4M | — | ||
| Q3 25 | $147.9M | — | ||
| Q2 25 | $117.8M | — | ||
| Q1 25 | $99.9M | — | ||
| Q4 24 | $122.7M | — | ||
| Q3 24 | $130.3M | — | ||
| Q2 24 | $114.0M | — | ||
| Q1 24 | $106.0M | — |
总债务ATRCPLPC
| Q4 25 | — | $38.3M | ||
| Q3 25 | $61.9M | $36.0M | ||
| Q2 25 | $61.9M | $31.8M | ||
| Q1 25 | $61.9M | $29.1M | ||
| Q4 24 | — | $20.8M | ||
| Q3 24 | $61.9M | $27.2M | ||
| Q2 24 | $61.9M | $31.6M | ||
| Q1 24 | $61.9M | $55.0M |
股东权益ATRCPLPC
| Q4 25 | $491.9M | $475.5M | ||
| Q3 25 | $476.5M | $466.3M | ||
| Q2 25 | $464.5M | $460.7M | ||
| Q1 25 | $454.6M | $435.8M | ||
| Q4 24 | $461.0M | $422.3M | ||
| Q3 24 | $465.0M | $429.0M | ||
| Q2 24 | $462.1M | $416.2M | ||
| Q1 24 | $456.3M | $413.4M |
总资产ATRCPLPC
| Q4 25 | $654.2M | $653.6M | ||
| Q3 25 | $635.4M | $644.6M | ||
| Q2 25 | $608.8M | $631.5M | ||
| Q1 25 | $591.6M | $592.5M | ||
| Q4 24 | $609.3M | $573.9M | ||
| Q3 24 | $615.1M | $592.0M | ||
| Q2 24 | $597.3M | $572.6M | ||
| Q1 24 | $591.6M | $586.1M |
负债/权益比ATRCPLPC
| Q4 25 | — | 0.08× | ||
| Q3 25 | 0.13× | 0.08× | ||
| Q2 25 | 0.13× | 0.07× | ||
| Q1 25 | 0.14× | 0.07× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | 0.13× | 0.06× | ||
| Q2 24 | 0.13× | 0.08× | ||
| Q1 24 | 0.14× | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.0M | $21.9M |
| 自由现金流经营现金流 - 资本支出 | $18.4M | $11.8M |
| 自由现金流率自由现金流/营收 | 13.1% | 6.8% |
| 资本支出强度资本支出/营收 | 1.1% | 5.9% |
| 现金转化率经营现金流/净利润 | — | 2.60× |
| 过去12个月自由现金流最近4个季度 | $48.3M | $33.3M |
8季度趋势，按日历期对齐
经营现金流ATRCPLPC
| Q4 25 | $20.0M | $21.9M | ||
| Q3 25 | $26.7M | $18.9M | ||
| Q2 25 | $21.6M | $26.9M | ||
| Q1 25 | $-11.0M | $5.7M | ||
| Q4 24 | $5.8M | $24.1M | ||
| Q3 24 | $20.0M | $9.4M | ||
| Q2 24 | $7.4M | $28.3M | ||
| Q1 24 | $-21.0M | $5.8M |
自由现金流ATRCPLPC
| Q4 25 | $18.4M | $11.8M | ||
| Q3 25 | $24.1M | $8.3M | ||
| Q2 25 | $19.0M | $18.6M | ||
| Q1 25 | $-13.2M | $-5.3M | ||
| Q4 24 | $3.1M | $20.6M | ||
| Q3 24 | $16.4M | $5.8M | ||
| Q2 24 | $5.0M | $24.6M | ||
| Q1 24 | $-23.8M | $1.8M |
自由现金流率ATRCPLPC
| Q4 25 | 13.1% | 6.8% | ||
| Q3 25 | 18.0% | 4.7% | ||
| Q2 25 | 13.9% | 10.9% | ||
| Q1 25 | -10.7% | -3.6% | ||
| Q4 24 | 2.5% | 12.3% | ||
| Q3 24 | 14.1% | 3.9% | ||
| Q2 24 | 4.3% | 17.7% | ||
| Q1 24 | -21.9% | 1.3% |
资本支出强度ATRCPLPC
| Q4 25 | 1.1% | 5.9% | ||
| Q3 25 | 1.9% | 6.0% | ||
| Q2 25 | 2.0% | 4.9% | ||
| Q1 25 | 1.8% | 7.4% | ||
| Q4 24 | 2.2% | 2.1% | ||
| Q3 24 | 3.1% | 2.4% | ||
| Q2 24 | 2.1% | 2.7% | ||
| Q1 24 | 2.5% | 2.8% |
现金转化率ATRCPLPC
| Q4 25 | — | 2.60× | ||
| Q3 25 | — | 7.21× | ||
| Q2 25 | — | 2.12× | ||
| Q1 25 | — | 0.49× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | — | 1.22× | ||
| Q2 24 | — | 3.02× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRC
| Appendage Management | $45.5M | 32% |
| Openheart | $38.5M | 27% |
| Other | $26.2M | 19% |
| Pain Management | $22.6M | 16% |
| Minimally Invasive | $7.7M | 6% |
PLPC
暂无分部数据
